PTSD study: Cognitive Processing Therapy vs STAIR Narrative Therapy
Official title A Comparative Effectiveness Study of PTSD Treatments Among Sexual and Gender Minority Populations
ClinicalTrials.gov ID: NCT06367764
What this study is testing
- What it's testing
- This study is testing whether two talk therapies help reduce PTSD symptoms. It also looks at how these treatments affect quality of life and depression.
- Who it's for
- You may be able to join if you are an adult with PTSD and identify as LGBTQIA+.
- What's involved
- You would get one of two types of talk therapy. You would also fill out questionnaires before and after your treatment.
- Time commitment
- The study lasts as long as your treatment and follow-up visits take.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years of age or older
- Currently live in California
- Ability to understand study procedures and to comply with them for the entire length of the study
- Ability to understand a written informed consent document and the willing to sign it
- Ability to speak and read English or Spanish
You likely can't join if
- Contraindication to any study-related procedure or assessment
- Clinically significant impairment which interferes with ability to fully participate in the study (including symptoms of schizophrenia...
- Active suicidal intent
See the full eligibility criteria
- 18 years of age or older
- Currently live in California
- Ability to understand study procedures and to comply with them for the entire length of the study
- Ability to understand a written informed consent document and the willing to sign it
- Ability to speak and read English or Spanish
- Identify as a sexual and/or gender minority
- Score 33 or higher on the PTSD Checklist-5 (PCL-5)
- Interest in getting treatment for PTSD
- Not be in another concurrent psychotherapy treatment (group or individual) for PTSD (psychotherapy treatment for non-PTSD conditions is allowed).
- Able to attend treatment sessions in person in San Francisco or have access to a device that allows for treatment via videoconferencing.
- Contraindication to any study-related procedure or assessment
- Clinically significant impairment which interferes with ability to fully participate in the study (including symptoms of schizophrenia, schizoaffective disorder, bipolar disorder, or other disorders)
- Active suicidal intent
The study team makes the final eligibility decision.
Where it is enrolling
- Palo Alto, California, United States
- San Francisco, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Palo Alto, California, United States; San Francisco, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.